Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 1/2022

01-01-2022 | Hepatitis A | Letter to the Editor

HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19

Authors: Luca Roncati, Antonio Manenti, Luca Fabbiani, Claudia Malagoli, Vincenzo Nasillo, Beatrice Lusenti, Massimo Lupi, Giuliana Zanelli, Tiziana Salviato, Matteo Costantini, Tommaso Trenti, Antonio Maiorana

Published in: Annals of Hematology | Issue 1/2022

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
Roncati L, Gallo G, Manenti A, Palmieri B (2020) Renin-angiotensin system: the unexpected flaw inside the human immune system revealed by SARS-CoV-2. Med Hypotheses 140:109686CrossRef
2.
3.
Roncati L, Palmieri B (2020) What about the original antigenic sin of the humans versus SARS-CoV-2? Med Hypotheses 142:109824CrossRef
4.
Ye Z, Wang Y, Colunga-Lozano LE, Prasad M, Tangamornsuksan W, Rochwerg B, Yao L, Motaghi S, Couban RJ, Ghadimi M, Bala MM, Gomaa H, Fang F, Xiao Y, Guyatt GH (2020) Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. CMAJ 192(27):756–767CrossRef
5.
Zhang C, Wu Z, Li JW, Zhao H, Wang GQ (2020) The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 55(5):105954CrossRef
6.
7.
Sheppard M, Laskou F, Stapleton PP, Hadavi S, Dasgupta B (2017) Tocilizumab (Actemra). Hum Vaccin Immunother 13(9):1972–1988CrossRef
8.
Roncati L, Ligabue G, Fabbiani L, Malagoli C, Gallo G, Lusenti B, Nasillo V, Manenti A, Maiorana A (2020) Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol 217:108487CrossRef
9.
Roncati L, Nasillo V, Lusenti B, Riva G (2020) Signals of Th2 immune response from COVID-19 patients requiring intensive care. Ann Hematol 99(6):1419–1420CrossRef
10.
Naaraayan A, Kavian R, Lederman J, Basak P, Jesmajian S (2015) Invasive pulmonary aspergillosis - case report and review of literature. J Community Hosp Intern Med Perspect 5(1):26322CrossRef
11.
Then EO, Gayam V, Are VS, Sunkara T, Gaduputi V (2019) Herpes simplex virus hepatitis: a brief review of an oft-overlooked pathology. Cureus 11(3):e4313PubMedPubMedCentral
Metadata
Title
HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19
Authors
Luca Roncati
Antonio Manenti
Luca Fabbiani
Claudia Malagoli
Vincenzo Nasillo
Beatrice Lusenti
Massimo Lupi
Giuliana Zanelli
Tiziana Salviato
Matteo Costantini
Tommaso Trenti
Antonio Maiorana
Publication date
01-01-2022
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 1/2022
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-021-04417-y

Other articles of this Issue 1/2022

Annals of Hematology 1/2022 Go to the issue

Original Article

Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre

Original Article

Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared with real-world data

Original Article

Prevalence of and risk factors for obstructive sleep apnea in children with sickle cell: a multicentric cross sectional study

Letter to the Editor

Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient

Original Article

Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis

Original Article

Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits